News24.com | WATCH | AstraZeneca shares dip after $39 billion Alexion deal

AstraZeneca shares fell on Monday, as investors moved to price in the British drugmaker's $39 billion deal for US biotech firm Alexion Pharmaceuticals, the company's largest ever takeover and one of this year's biggest mergers globally.